Boltwood Capital Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-3,830
Closed -$678K 133
2020
Q1
$678K Hold
3,830
0.48% 72
2019
Q4
$732K Sell
3,830
-1,185
-24% -$214K 0.41% 80
2019
Q3
$844K Buy
5,015
+30
+0.6% +$4.89K 0.53% 65
2019
Q2
$835K Buy
4,985
+1,025
+26% +$142K 0.53% 66
2019
Q1
$580K Buy
+3,960
New +$574K 0.38% 79
2018
Q4
Sell
-5,081
Closed -$967K 137
2018
Q3
$967K Buy
5,081
+270
+6% +$49.6K 0.58% 56
2018
Q2
$802K Buy
4,811
+215
+5% +$34.5K 0.52% 64
2018
Q1
$773K Buy
4,596
+61
+1% +$10.2K 0.53% 60
2017
Q4
$741K Buy
4,535
+120
+3% +$21.5K 0.45% 68
2017
Q3
$904K Buy
4,415
+25
+0.6% +$5.81K 0.59% 60
2017
Q2
$1.07M Buy
4,390
+475
+12% +$112K 0.72% 45
2017
Q1
$935K Buy
+3,915
New +$912K 0.65% 51

Other funds holding AGN

Boltwood Capital Management's AGN Position: Q2 2020 in Review

Boltwood Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 3,830 shares — an estimated $678K sold.

Boltwood Capital Management first reported a position in AGN in Q1 2017 and held it in 12 quarters. The position peaked at $1.07M in Q2 2017. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Boltwood Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Boltwood Capital Management sold 3,830 Allergan plc shares in Q2 2020, an estimated $678K.
  • Boltwood Capital Management first reported a position in Allergan plc in Q1 2017 and held it in 12 quarters.
  • Boltwood Capital Management's Allergan plc position peaked at $1.07M in Q2 2017.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Boltwood Capital Management's 13F filing for Q2 2020, filed 2 Jul 2020.